X |
Filing Date |
Trade Date |
Ticker |
Insider Name | Title |
Trade Type |
Price |
Qty |
Owned |
ΔOwn |
Value |
1d |
1w |
1m |
6m |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
2024-07-15 | PHAT | Nabulsi Azmi | COO | S - Sale | $11.72 | -10,901 | 1,029,700 | -1% | -$127,760 | ||||||
2024-07-15 | PHAT | Henderson Molly | CFO, CBO | S - Sale | $11.72 | -4,325 | 101,358 | -4% | -$50,689 | ||||||
2024-07-15 | PHAT | Curran Terrie | Pres, Chief Exec | S - Sale | $11.72 | -33,848 | 381,574 | -8% | -$396,699 | ||||||
2024-04-08 | PHAT | Henderson Molly | CFO, CBO | S - Sale | $11.10 | -3,435 | 97,174 | -3% | -$38,129 | ||||||
2024-03-22 | PHAT | Curran Terrie | Pres, Chief Exec | S - Sale | $9.11 | -16,851 | 414,624 | -4% | -$153,513 | ||||||
2024-01-24 | PHAT | Takeda Pharmaceutical Co Ltd | 10% | S - Sale | $8.10 | -3,703,703 | 3,755,583 | -50% | -$29,999,994 | ||||||
| D | 2024-01-19 | PHAT | Henderson Molly | CFO, CBO | S - Sale+OE | $7.75 | -6,307 | 100,609 | -6% | -$48,900 | |||||
2023-11-20 | PHAT | Henderson Molly | CFO, CBO | S - Sale | $7.24 | -2,127 | 104,195 | -2% | -$15,403 | ||||||
| M | 2023-11-06 | PHAT | Parikh Asit | Dir | P - Purchase | $7.81 | +7,500 | 55,000 | +16% | +$58,580 | |||||
2023-11-01 | PHAT | Henderson Molly | CFO, CBO | S - Sale | $8.88 | -12,492 | 106,322 | -11% | -$110,871 | ||||||
2023-06-02 | PHAT | Henderson Molly | CFO, CBO | S - Sale | $11.41 | -1,960 | 68,845 | -3% | -$22,368 | ||||||
2023-05-22 | PHAT | Henderson Molly | CFO, CBO | S - Sale | $12.87 | -2,110 | 70,805 | -3% | -$27,165 | ||||||
2023-04-10 | PHAT | Parikh Asit | Dir | P - Purchase | $7.55 | +1,000 | 23,500 | +4% | +$7,550 | ||||||
2023-04-11 | PHAT | Nabulsi Azmi | COO | P - Purchase | $8.26 | +10,000 | 887,622 | +1% | +$82,600 | ||||||
2023-04-06 | PHAT | Curran Terrie | Pres, Chief Exec | P - Purchase | $7.82 | +12,919 | 190,526 | +7% | +$101,025 | ||||||
2023-04-06 | PHAT | Henderson Molly | CFO, CBO | S - Sale | $7.27 | -3,439 | 72,915 | -5% | -$25,002 | ||||||
2023-03-01 | PHAT | Henderson Molly | CFO, CBO | S - Sale | $8.53 | -2,032 | 76,354 | -3% | -$17,335 | ||||||
2023-03-01 | PHAT | Curran Terrie | Pres, Chief Exec | S - Sale | $8.54 | -1,436 | 177,607 | -1% | -$12,265 | ||||||
2023-02-13 | PHAT | Parikh Asit | Dir | P - Purchase | $7.73 | +5,000 | 22,500 | +29% | +$38,660 | ||||||
| D | 2023-01-20 | PHAT | Curran Terrie | Pres, Chief Exec | S - Sale+OE | $8.20 | -5,821 | 179,043 | -3% | -$47,729 | |||||
2023-01-12 | PHAT | Parikh Asit | Dir | P - Purchase | $7.00 | +5,000 | 17,500 | +40% | +$35,000 |
| A | Amended filing |
| D | Derivative transaction in filing (usually option exercise) |
| E | Error detected in filing |
| M | Multiple transactions in filing; earliest reported transaction date and weighted average transaction price |
| S - Sale | Sale of securities on an exchange or to another person |
| S - Sale+OE | Sale of securities on an exchange or to another person (after option exercise) |
| F - Tax | Payment of exercise price or tax liability using portion of securities received from the company |
| P - Purchase | Purchase of securities on an exchange or from another person |